Biomarkers – Multimedia

Join Bruker's Erica Forsberg with Sapient Founder & CEO Mohit Jain, & Co-Founder and Head of Analytical R&D, Jeramie Watrous as they take you behind the scenes of Sapient’s lab.

The need for molecular diagnostic assays is growing at an unprecedented rate and the discovery of new biomarkers and improved accessibility to standard catalog reagents has allowed the creation of molecular tests faster than ever before.

Immunotherapy using immune checkpoint inhibitors (ICI) has revolutionized the treatment landscape in oncology, but significant challenges remain. Without reliable tools to identify likely responders, patients who may have responded are not prescribed ICIs.

Download this eBook to explore how these new technologies have enabled some of the most recent discoveries in areas such as molecular mechanisms of cancer, cancer biomarkers as well as vaccines and therapeutics to tackle cancer.

Download this whitepaper to review the exciting technology behind the advances in data independent acquisition and explore how it can enhance your research.

While CRISPR-edited cell lines can be beneficial for target identification, reagent validation, and biomarker discovery, generating high-quality cell lines can be fraught with difficulties and time-consuming and relies on several factors.

Speaking at Advances in Proteomics and Metabolomics 2021, Chris Wiley from Jean Mayer USDA Human Nutrition Research Center on Aging, presented his talk on cellular senescence and novel methods to detect senolysis.

Speaking at Advances in Proteomics and Metabolomics 2021, Gary Kruppa from Bruker, presented his talk on the latest applications of 4D-proteomics using the timsTOF.

Speaking in June 2021 at the online symposium, Advances in Proteomics & Metabolomics, Prof. Stephen Pennington, Professor of Proteomics at University College Dublin presented his keynote talk on developing advanced protein
biomarker tests for psoriatic disease.

Harness the power of Zeno SWATH data independent acquisition (DIA) to deliver a high depth of coverage, particularly on low abundance species, quickly and robustly.